Vidaza and respiratory failure Patient Reports February 10, 2010

Vidaza Side Effects Report #4648977-3
Vidaza side effect was reported by a Physician from on Apr 12, 2005. Male patient, 81 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: atrial fibrillation , atrial flutter, febrile neutropenia, hypercapnia, hyperglycaemia, renal failure acute, respiratory failure, white blood cell count decreased. Vidaza dosage: unknown. During the same period patient was treated with THALOMID. Patient was hospitalized. Patient died on 11/29/2004.

Vidaza Side Effects Report #4867503-7
Vidaza side effect was reported by a Physician from UNITED STATES on Dec 08, 2005. Female patient, 65 years of age, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: hypotension, injection site haemorrhage, injection site pain, intestinal ischaemia, multi-organ failure, renal failure, respiratory failure, sepsis , thrombosis mesenteric vessel. Vidaza dosage: 75 MG/M2 (DAILY X 5. Patient died on 08/23/2005.

Vidaza Side Effects Report #5614727-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, 56 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, pneumocystis jiroveci pneumonia, refusal of treatment by relative, respiratory failure, tachycardia. Vidaza dosage: 230 MG, DAILY. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.

Vidaza Side Effects Report #5467580-9
Vidaza side effect was reported by a Physician from UNITED STATES on Sept 07, 2007. Male patient, 43 years of age, weighting 242.5 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal pain , acute febrile neutrophilic dermatosis, post procedural haematoma, renal failure, respiratory failure, sepsis , vocal cord disorder. Vidaza dosage: (75 MG/M2, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VORINOSTAT. Patient was hospitalized. Patient recovered.


Vidaza Side Effects Report #5526552-6
Vidaza side effect was reported by a Pharmacist from UNITED STATES on Nov 21, 2007. Male patient, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, insomnia, pneumonia , refusal of treatment by relative, respiratory failure, tachycardia, tuberculosis . Vidaza dosage: 230MG DAILY IV; 10 CYLES. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.

Vidaza Side Effects Report #5803583-X
Vidaza side effect was reported by a Physician from GERMANY on June 18, 2008. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: lung infiltration, neutropenia, respiratory failure. Vidaza dosage: (143 MG, X 5 DAYS), SUBCUTANEOUS. Patient was hospitalized. Patient died on 06/17/2008.

Vidaza Side Effects Report #5804541-1
Vidaza side effect was reported by a Physician from GERMANY on June 24, 2008. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: lung infiltration, neutropenia, respiratory failure, white blood cell count decreased. Vidaza dosage: (143 MG, 5 D, SUBCUTANEOUS). Patient was hospitalized. Patient died on 06/17/2008.

Vidaza Side Effects Report #5993133-X
Vidaza side effect was reported by a Consumer or non-health professional from GERMANY on Nov 27, 2008. Female patient, 49 years of age, weighting 264.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: bronchopulmonary aspergillosis, respiratory failure. Vidaza dosage: unknown. During the same period patient was treated with PERINDOPRIL PLUS INDAPAMID. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5929378-4
Vidaza side effect was reported by a Physician from GERMANY on Oct 09, 2008. Female patient, 49 years of age, weighting 264.6 lb, was treated with Vidaza. After drug was administered, patient experienced the following side effects: pneumonia fungal, respiratory failure. Vidaza dosage: (78 MG/M2), SUBCUTANEOUS. Patient was hospitalized. Patient recovered.